Last edition
News about "DRDO invites EoI to transfer technology of 2-DG dr"
DRDO invites EoI to transfer technology of 2-DG drug for bulk production
The Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of Covid-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical industries for production
DRDO Invites EoI To Transfer Technology Of 2-DG Dr | 10/06/2021 | By Darshana | 349
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members